| Year |
Citation |
Score |
| 2024 |
Olayiwola JO, Marhabaie M, Koboldt D, Matthews T, Siemon A, Mouhlas D, Porter T, Kyle G, Myers C, Mei H, Hou YC, Babcock M, Hunter J, Schieffer KM, Akkari Y, ... Reshmi S, et al. Clinically significant findings in a decade-long retrospective study of prenatal chromosomal microarray testing. Molecular Genetics & Genomic Medicine. e2349. PMID 38263869 DOI: 10.1002/mgg3.2349 |
0.344 |
|
| 2022 |
Brady SW, Roberts KG, Gu Z, Shi L, Pounds S, Pei D, Cheng C, Dai Y, Devidas M, Qu C, Hill AN, Payne-Turner D, Ma X, Iacobucci I, Baviskar P, ... ... Reshmi SC, et al. The genomic landscape of pediatric acute lymphoblastic leukemia. Nature Genetics. PMID 36050548 DOI: 10.1038/s41588-022-01159-z |
0.373 |
|
| 2021 |
Akhavanfard S, Nohr E, AlNajjar M, Haughn M, Hashimoto S, Deeg C, Pfau R, Brundler MA, Reshmi SC. 5' Amplification in Neuroblastoma: A Case Report. Case Reports in Oncology. 14: 585-591. PMID 33976638 DOI: 10.1159/000512187 |
0.387 |
|
| 2019 |
Pfeifer H, Cazzaniga G, van der Velden VHJ, Cayuela JM, Schäfer B, Spinelli O, Akiki S, Avigad S, Bendit I, Borg K, Cavé H, Elia L, Reshmi SC, Gerrard G, Hayette S, et al. Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia. PMID 30858550 DOI: 10.1038/S41375-019-0413-0 |
0.335 |
|
| 2019 |
Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, ... ... Reshmi SC, et al. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nature Genetics. PMID 30643249 DOI: 10.1038/S41588-018-0315-5 |
0.381 |
|
| 2019 |
Roberts KG, Brady SW, Gu Z, Shi L, Pounds S, Pei D, Cheng C, Dai Y, Devidas M, Qu C, Hill A, Ma X, Wei L, Arunachalam S, Hagiwara K, ... ... Reshmi SC, et al. The Genomic Landscape of Childhood Acute Lymphoblastic Leukemia Blood. 134: 649-649. DOI: 10.1182/Blood-2019-124881 |
0.409 |
|
| 2018 |
Roberts KG, Reshmi SC, Harvey RC, Chen IM, Patel K, Stonerock E, Jenkins H, Dai Y, Valentine M, Gu Z, Zhao Y, Zhang J, Payne-Turner D, Devidas M, Heerema NA, et al. Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group. Blood. PMID 29997224 DOI: 10.1182/Blood-2018-04-841676 |
0.331 |
|
| 2018 |
Barrie ES, Li Y, Lamb-Thrush D, Hashimoto S, Jacobson T, Mouhlas D, Pyatt R, Reshmi SC, Gastier-Foster JM, Pfau R, Astbury C. Pericentromeric regions of homozygosity on the X chromosome: Another likely benign population variant. European Journal of Medical Genetics. PMID 29572065 DOI: 10.1016/J.Ejmg.2018.02.008 |
0.435 |
|
| 2018 |
Tran TH, Harris MH, Nguyen JV, Blonquist TM, Stevenson KE, Stonerock E, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, ... ... Reshmi SC, et al. Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia. Blood Advances. 2: 529-533. PMID 29507076 DOI: 10.1182/Bloodadvances.2017014704 |
0.373 |
|
| 2018 |
Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, ... ... Reshmi SC, et al. Characterization of Novel Subtypes in B Progenitor Acute Lymphoblastic Leukemia Blood. 132: 565-565. DOI: 10.1182/Blood-2018-99-111219 |
0.386 |
|
| 2017 |
Santoro SL, Hashimoto S, McKinney A, Mihalic Mosher T, Pyatt R, Reshmi SC, Astbury C, Hickey SE. Assessing the Clinical Utility of SNP Microarray for Prader-Willi Syndrome due to Uniparental Disomy. Cytogenetic and Genome Research. PMID 28746920 DOI: 10.1159/000478921 |
0.354 |
|
| 2017 |
Reshmi SC, Harvey RC, Roberts KG, Stonerock E, Smith A, Jenkins H, Chen IM, Valentine M, Liu Y, Li Y, Shao Y, Easton J, Payne-Turner D, Tran TH, Nguyen JV, et al. Targetable kinase gene fusions in high risk B-ALL: a study from the Children's Oncology Group. Blood. PMID 28408464 DOI: 10.1182/Blood-2016-12-758979 |
0.384 |
|
| 2017 |
Patel S, Mason CC, Glenn MJ, Paxton CN, South ST, Cessna MH, Asch J, Cobain EF, Bixby DL, Smith LB, Reshmi S, Gastier-Foster JM, Schiffman JD, Miles RR. Genomic analysis of adult B-ALL identifies potential markers of shorter survival. Leukemia Research. 56: 44-51. PMID 28193567 DOI: 10.1016/J.Leukres.2017.01.034 |
0.374 |
|
| 2016 |
Iacobucci I, Li Y, Roberts KG, Dobson SM, Kim JC, Payne-Turner D, Harvey RC, Valentine M, McCastlain K, Easton J, Yergeau D, Janke LJ, Shao Y, Chen IL, Rusch M, ... ... Reshmi S, et al. Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia. Cancer Cell. 29: 186-200. PMID 26859458 DOI: 10.1016/J.Ccell.2015.12.013 |
0.451 |
|
| 2016 |
Loh ML, Raetz E, Devidas M, Dai Y, Borowitz MJ, Carroll AJ, Chen I, Gastier-Foster JM, Friedmann AM, Harvey RC, Heerema NA, Larsen E, Li Y, Maloney KW, Mattano LA, ... ... Reshmi SC, et al. Outcomes of Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia Based on Blast Genotype at Diagnosis: A Report from the Children's Oncology Group Blood. 128: 451-451. DOI: 10.1182/Blood.V128.22.451.451 |
0.331 |
|
| 2016 |
Tran TH, Harris MH, Nguyen JV, Blonquist TM, Stevenson KE, Stonerock E, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc J, Michon B, Schorin MA, ... ... Reshmi SC, et al. Kinase-Activating Fusions in Pediatric High-Risk B-Lineage Acute Lymphoblastic Leukemia (ALL): a Report from the Dana-Farber Cancer Institute (DFCI) ALL Consortium Blood. 128: 1729-1729. DOI: 10.1182/Blood.V128.22.1729.1729 |
0.393 |
|
| 2015 |
Patel SB, Mason CC, Glenn M, Paxton CN, South ST, Cessna MH, Asch JD, Cobain EF, Bixby D, Smith LB, Reshmi SC, Gastier-Foster JM, Schiffman JD, Miles RR. Genomic Analysis of Adult B-ALL Identifies Changes in Copy Number Profile at Relapse and IKZF1/CDKN2A Co-Deletion at Diagnosis As a Marker of Shorter Survival Blood. 126: 1427-1427. DOI: 10.1182/Blood.V126.23.1427.1427 |
0.37 |
|
| 2015 |
Reshmi SC, Harvey RC, Smith A, Chen I, Valentine M, Liu Y, Li Y, Zhang J, Roberts KG, Shao Y, Easton J, Payne-Turner D, Devidas M, Heerema N, Carroll AJ, et al. Abstract 4729: Frequency of actionable gene fusions in patients with Philadelphia chromosome-like (Ph-like) B-acute lymphoblastic leukemia (ALL): A retrospective study from the Children's Oncology Group (COG) Cancer Research. 75: 4729-4729. DOI: 10.1158/1538-7445.Am2015-4729 |
0.368 |
|
| 2014 |
Gollin SM, Reshmi SC. Janet Davison Rowley, M.D. (1925–2013). American Journal of Human Genetics. 94: 805-8. PMID 25035867 DOI: 10.1016/J.Ajhg.2014.05.008 |
0.523 |
|
| 2014 |
Walters-Sen LC, Thrush DL, Hickey SE, Hashimoto S, Reshmi S, Gastier-Foster JM, Pyatt RE, Astbury C. Atypical breakpoint in a t(6;17) translocation case of acampomelic campomelic dysplasia. European Journal of Medical Genetics. 57: 315-8. PMID 24821304 DOI: 10.1016/J.Ejmg.2014.04.018 |
0.405 |
|
| 2014 |
Polan MB, Pastore MT, Steingass K, Hashimoto S, Thrush DL, Pyatt R, Reshmi S, Gastier-Foster JM, Astbury C, McBride KL. Neurodevelopmental disorders among individuals with duplication of 4p13 to 4p12 containing a GABAA receptor subunit gene cluster. European Journal of Human Genetics : Ejhg. 22: 105-9. PMID 23695283 DOI: 10.1038/Ejhg.2013.99 |
0.37 |
|
| 2014 |
Roberts KG, Yang Y, Payne-Turner D, Harvey RC, Chen I, Reshmi SC, Julie G, Loh ML, Willman CL, Hunger SP, Mullighan CG. Functional Analysis of Kinase-Activating Fusions in Ph-like Acute Lymphoblastic Leukemia Blood. 124: 786-786. DOI: 10.1182/Blood.V124.21.786.786 |
0.381 |
|
| 2014 |
Roberts KG, Li Y, Payne-Turner D, Zhang J, Harvey RC, Yang Y, Song G, Ma J, Chen S, Cheng J, Santiago-Morales N, Iacobucci I, Devidas M, Chen I, Reshmi S, et al. Abstract 3083: The genetic landscape of Ph-like acute lymphoblastic leukemia Cancer Research. 74: 3083-3083. DOI: 10.1158/1538-7445.Am2014-3083 |
0.359 |
|
| 2013 |
Repnikova EA, Rosenfeld JA, Bailes A, Weber C, Erdman L, McKinney A, Ramsey S, Hashimoto S, Lamb Thrush D, Astbury C, Reshmi SC, Shaffer LG, Gastier-Foster JM, Pyatt RE. Characterization of copy number variation in genomic regions containing STR loci using array comparative genomic hybridization. Forensic Science International. Genetics. 7: 475-81. PMID 23948316 DOI: 10.1016/J.Fsigen.2013.05.008 |
0.375 |
|
| 2013 |
Hickey SE, Thrush DL, Walters-Sen L, Reshmi SC, Astbury C, Gastier-Foster JM, Atkin J. A case of an atypically large proximal 15q deletion as cause for Prader-Willi syndrome arising from a de novo unbalanced translocation. European Journal of Medical Genetics. 56: 510-4. PMID 23856564 DOI: 10.1016/J.Ejmg.2013.05.010 |
0.491 |
|
| 2013 |
Harvey RC, Kang H, Roberts KG, Chen IL, Atlas SR, Bedrick EJ, Gastier-Foster JM, Zhang J, Gerhard DS, Smith MA, Larsen EC, Raetz EA, Winick NJ, Carroll WL, Stonerock E, ... ... Reshmi SC, et al. Development and Validation Of a Highly Sensitive and Specific Gene Expression Classifier To Prospectively Screen and Identify B-Precursor Acute Lymphoblastic Leukemia (ALL) Patients With a Philadelphia Chromosome-Like (“Ph-like” or “BCR-ABL1-Like”) Signature For Therapeutic Targeting and Clinical Intervention Blood. 122: 826-826. DOI: 10.1182/Blood.V122.21.826.826 |
0.372 |
|
| 2012 |
Alyaqoub F, Pyatt RE, Bailes A, Brock A, Deeg C, McKinney A, Astbury C, Reshmi S, Shane KP, Thrush DL, Sommer A, Gastier-Foster JM. 12q14 microdeletion associated with HMGA2 gene disruption and growth restriction. American Journal of Medical Genetics. Part A. 158: 2925-30. PMID 22987822 DOI: 10.1002/Ajmg.A.35610 |
0.428 |
|
| 2012 |
Repnikova EA, Astbury C, Reshmi SC, Ramsey SN, Atkin JF, Thrush DL, Mitchell AL, Pyatt RE, Reber K, Slavin T, Gastier-Foster JM. Microarray comparative genomic hybridization and cytogenetic characterization of tissue-specific mosaicism in three patients. American Journal of Medical Genetics. Part A. 158: 1924-33. PMID 22786685 DOI: 10.1002/Ajmg.A.35477 |
0.445 |
|
| 2012 |
Chen IM, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, Pullen DJ, Payne-Turner D, Tasian SK, Reshmi S, Cottrell CE, et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 119: 3512-22. PMID 22368272 DOI: 10.1182/Blood-2011-11-394221 |
0.321 |
|
| 2011 |
Reshmi SC, Miller JL, Deplewski D, Close C, Henderson LJ, Littlejohn E, Schwartz S, Waggoner DJ. Evidence of a mechanism for isodicentric chromosome Y formation in a 45,X/46,X,idic(Y)(p11.31)/46,X,del(Y)(p11.31) mosaic karyotype. European Journal of Medical Genetics. 54: 161-4. PMID 21078420 DOI: 10.1016/J.Ejmg.2010.11.002 |
0.43 |
|
| 2010 |
Cottrell CE, Prior TW, Pyatt R, Astbury C, Reshmi S, Bartholomew D, Atkin J, Manickam K, Thrush DL, Pastore M, Mendell J, Tsao CY, Al-Dahhak R, Newmeyer A, Gastier-Foster JM. Unexpected detection of dystrophin gene deletions by array comparative genomic hybridization. American Journal of Medical Genetics. Part A. 152: 2301-7. PMID 20683981 DOI: 10.1002/Ajmg.A.33532 |
0.349 |
|
| 2010 |
Rosales XQ, Gastier-Foster JM, Lewis S, Vinod M, Thrush DL, Astbury C, Pyatt R, Reshmi S, Sahenk Z, Mendell JR. Novel diagnostic features of dysferlinopathies. Muscle & Nerve. 42: 14-21. PMID 20544924 DOI: 10.1002/Mus.21650 |
0.317 |
|
| 2010 |
Qian Z, Joslin JM, Tennant TR, Reshmi SC, Young DJ, Stoddart A, Larson RA, Le Beau MM. Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. Chemico-Biological Interactions. 184: 50-7. PMID 19958752 DOI: 10.1016/J.Cbi.2009.11.025 |
0.499 |
|
| 2009 |
Carroll AJ, Heerema NA, Gastier-Foster JM, Astbury C, Pyatt R, Reshmi SC, Borowitz MJ, Devidas M, Linda S, Loh ML, Raetz EA, Wood B, Winick NJ, Hunger SP, Carroll WL. Masked Hypodiploidy: Hypodiploid Acute Lymphoblastic Leukemia (ALL) in Children Mimicking Hyperdiploid ALL: A Report From the Children's Oncology Group (COG) AALL03B1 Study. Blood. 114: 1580-1580. DOI: 10.1182/Blood.V114.22.1580.1580 |
0.503 |
|
| 2008 |
Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, Reddy JK, Khanna P, Johnson JT, Myers EN, Gollin SM. Chromosomal imbalances in oral squamous cell carcinoma: Examination of 31 cell lines and review of the literature Oral Oncology. 44: 369-382. PMID 17681875 DOI: 10.1016/J.Oraloncology.2007.05.003 |
0.678 |
|
| 2007 |
Reshmi SC, Roychoudhury S, Yu Z, Feingold E, Potter D, Saunders WS, Gollin SM. Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification. Cytogenetic and Genome Research. 116: 46-52. PMID 17268177 DOI: 10.1159/000097425 |
0.682 |
|
| 2007 |
Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, Smith DI, Gollin SM. Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes, Chromosomes & Cancer. 46: 143-54. PMID 17099871 DOI: 10.1002/Gcc.20394 |
0.684 |
|
| 2006 |
Wittschieben JP, Reshmi SC, Gollin SM, Wood RD. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Research. 66: 134-42. PMID 16397225 DOI: 10.1158/0008-5472.Can-05-2982 |
0.647 |
|
| 2006 |
Gollin SM, Parikh RA, White JS, Huang X, Baskaran R, Saunders WS, Bakkenist CJ, Reshmi SC. S041 Identification of the Mechanism of 11q13 Amplification Leads to Detection of DNA Repair Defects in HNSCC Cell Lines Archives of Otolaryngology–Head & Neck Surgery. 132: 848. DOI: 10.1001/Archotol.132.8.848-A |
0.692 |
|
| 2005 |
Cook JR, Aguilera NI, Reshmi S, Huang X, Yu Z, Gollin SM, Abbondanzo SL, Swerdlow SH. Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma. Cancer Genetics and Cytogenetics. 162: 85-8. PMID 16157207 DOI: 10.1016/J.Cancergencyto.2005.04.013 |
0.642 |
|
| 2005 |
Reshmi SC, Gollin SM. Chromosomal instability in oral cancer cells. Journal of Dental Research. 84: 107-17. PMID 15668327 DOI: 10.1177/154405910508400203 |
0.665 |
|
| 2004 |
Reshmi SC, Saunders WS, Kudla DM, Ragin CR, Gollin SM. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma. Genes, Chromosomes & Cancer. 41: 38-46. PMID 15236315 DOI: 10.1002/Gcc.20064 |
0.671 |
|
| 2004 |
Ragin CC, Reshmi SC, Gollin SM. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. International Journal of Cancer. Journal International Du Cancer. 110: 701-9. PMID 15146560 DOI: 10.1002/Ijc.20193 |
0.615 |
|
| 1999 |
Martinez-Climent JA, Comes AM, Vizcarra E, Reshmi S, Benet I, Marugan I, Tormo M, Terol MJ, Solano C, Arbona C, Prosper F, Barragan E, Bolufer P, Rowley JD, García-Conde J. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis. Cancer Genetics and Cytogenetics. 110: 111-4. PMID 10214358 DOI: 10.1016/S0165-4608(98)00187-3 |
0.516 |
|
| 1999 |
Fleischman EW, Reshmi S, Sokova OI, Kirichenko OP, Konstantinova LN, Kulagina OE, Frenkel MA, Rowley JD. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genetics and Cytogenetics. 108: 166-70. PMID 9973948 DOI: 10.1016/S0165-4608(98)00137-X |
0.416 |
|
| 1999 |
Fleischman EW, Reshmi S, Frenkel MA, Konovalova WI, Guleva GP, Kulagina OE, Konstantinova LN, Tupitsyn NN, Rowley JD. MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia. Genes, Chromosomes & Cancer. 24: 151-5. PMID 9885982 DOI: 10.1002/(Sici)1098-2264(199902)24:2<151::Aid-Gcc8>3.0.Co;2-E |
0.445 |
|
| 1999 |
Rowley JD, Reshmi S, Carlson K, Roulston D. Spectral Karyotype Analysis of T-Cell Acute Leukemia Blood. 93: 2038-2042. DOI: 10.1182/Blood.V93.6.2038.406A32_2038_2042 |
0.459 |
|
| 1997 |
Super HG, Strissel PL, Sobulo OM, Burian D, Reshmi SC, Roe B, Zeleznik-Le NJ, Diaz MO, Rowley JD. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia Genes Chromosomes and Cancer. 20: 185-195. PMID 9331569 DOI: 10.1002/(Sici)1098-2264(199710)20:2<185::Aid-Gcc9>3.0.Co;2-# |
0.486 |
|
| 1997 |
Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proceedings of the National Academy of Sciences of the United States of America. 94: 8732-7. PMID 9238046 DOI: 10.1073/Pnas.94.16.8732 |
0.339 |
|
| 1997 |
Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Borrow J, Zeleznik-Le N. All patients with the t(11; 16)(q23; p13.3) That involves MLL and CBP have treatment-related hematologic disorders Blood. 90: 535-541. PMID 9226152 |
0.353 |
|
| 1997 |
Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Borrow J, Zeleznik-Le N. All Patients With the T(11; 16)(q23; p13.3) That Involves MLL and CBP Have Treatment-Related Hematologic Disorders Blood. 90: 535-541. DOI: 10.1182/Blood.V90.2.535.535_535_541 |
0.449 |
|
| Show low-probability matches. |